Last reviewed · How we verify

NCT03906955

A Video Chat Intervention for Enhancing Self-efficacy for Lifestyle Physical Activity

Completed NA Last updated 24 October 2019
What this trial tests

NA trial testing Efficacy for Lifestyle PA in Physical Activity in 72 participants. Completed in 15 September 2019.

Timeline
9 April 2019
Primary endpoint
15 September 2019
15 September 2019

Quick facts

Lead sponsorUniversity of Illinois at Urbana-Champaign
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment72
Start date9 April 2019
Primary completion15 September 2019
Estimated completion15 September 2019
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Illinois at Urbana-Champaign

Who can join

Adults 25 to 64, any sex, with Physical Activity or Self Efficacy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate the efficacy of three, brief (10-minute) theory-guided video chats for increasing self-efficacy for lifestyle physical activity versus a time-matched video chat comparison group designed to increase self-efficacy for work-life balance. Participants will include individuals who are low-active, full-time (\>35 hours/week) working adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Physical Activity

Currently open trials in the same condition.

Other University of Illinois at Urbana-Champaign trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03906955.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing